[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] Fwd: E-News 02/19/02

>From: "Dr. Joe, The Diabetes Doctor" <email @ redacted>
>To: (Recipient list suppressed)
>Subject: E-News 02/19/02
>Date: Tue, 19 Feb 2002 02:40:00 -0800
>Dr. Joe and the team have been involved in development of this new product 
>and delighted to see it out there.
>SpectRx, Inc. Announces FDA Clearance of New Minimally Invasive Insulin 
>Delivery Patch for Insulin Pumps
>Monday February 4, 6:30 AM EST NORCROSS, Ga., Feb 4, 2002 
>/PRNewswire-FirstCall via COMTEX/ -- SpectRx, Inc. (SPRX
>today announced it received U.S. Food and Drug Administration (FDA) 
>clearance to market a new minimally invasive insulin infusion patch set for 
>use with insulin pumps. The new patch infusion set brings to 19 the number 
>of FDA clearances supporting SpectRx's insulin delivery product pipeline.
>These products were added to SpectRx's diabetes franchise through its 
>recent acquisition of Sterling Medivations. The new insulin patch infusion 
>set, which is expected to be on the market in 2003, will address a U.S. 
>insulin pump infusion set disposable market estimated at $200 million 
>annually and growing approximately 25 percent per year.
>The patch infusion set, designed for use with all makes of insulin pumps, 
>delivers insulin through five microneedles that are less than half the 
>length of ordinary insulin pump infusion needles. The reduced penetration 
>is designed to improve comfort and wearability.  "We believe that the novel 
>design of this new groundbreaking product will provide people who use 
>insulin pumps with a more comfortable, secure, easy to use and discreet 
>option," said SpectRx President and COO, Keith D. Ignotz.
>"This latest FDA clearance is an indication of the strength and depth of 
>our insulin delivery products pipeline," said Mark A. Samuels, SpectRx 
>Chairman and CEO. "After our initial product introductions of the Simple 
>Choice(TM) insulin pump infusion sets scheduled for later this year, we 
>expect to roll out new insulin delivery products at regular intervals, 
>providing innovation for people with diabetes and excellent growth 
>opportunities for SpectRx."
>In addition to the insulin patch infusion set, SpectRx has received FDA 
>clearance for soft catheter insulin pump infusion sets, an insulin pump 
>reservoir and a multi-purpose insulin pen. The first of these products, the 
>Simple Choice(TM) Soft and Simple Choice(TM) Quick insulin pump infusion 
>sets, are expected to launch by the third quarter of this year. The 
>Company's additional proprietary insulin delivery products under 
>development are designed to improve the quality of life for people with 
>diabetes who use insulin, most of whom still use conventional syringes.
>Insulin infusion sets, when attached to external pumps, provide a steady 
>stream of insulin for people with diabetes, helping them to better control 
>their disease. The disposable infusion sets are changed about every three 
>days. This is a growing market, with about 160,000 people with diabetes 
>using insulin pumps in the U.S in 2001. That number is expected to increase 
>to about 225,000 in 2002.
>SpectRx is a medical technology company providing innovative detection, 
>monitoring and treatment solutions for diabetes, cancer and other niche 
>healthcare markets. SpectRx is developing and will market the Simple 
>Choice(TM) line of innovative insulin delivery products for people with 
>diabetes. These products will complement SpectRx's consumer device for 
>continuous glucose monitoring being developed with partner Abbott 
>Laboratories. SpectRx is also developing, along with partner Welch Allyn, a 
>product for the non-invasive detection of cervical cancer based on its 
>biophotonic technology. SpectRx also developed and currently markets the 
>BiliChek(TM), a non-invasive, painless monitor for infant jaundice. SpectRx 
>was developed around its leading-edge biophotonic detection and monitoring 
>technology, which uses light and spectral energies to develop painless 
>alternatives to blood-based and tissue-based procedures. For more 
>information, visit SpectRx's web sites at www.spectrx.com and 
>www.bilicheck.com, or use Internet keyword spectrx.

Get your FREE download of MSN Explorer at http://explorer.msn.com/intl.asp.
for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml